Developer docs
API playgroundTry for free, no card

Search company profiles

Embion Technologies

Full company profile

uuid0002vle

Namestring
Embion Technologies
Legal namestring
Embion Technologies SA
Websiteurl
embiontech.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Embion Technologies SA is a Swiss biotech company headquartered in Etoy, Switzerland, founded in 2016 as a spin-off from EPFL (École Polytechnique Fédérale de Lausanne). The company develops a patented hydrolysis platform that breaks down the cell wall structure of second-generation biomass — specifically brewers' spent grains — to release bioactive molecules, which it positions as a circular-economy input for functional nutrition and sustainability applications.

The company's first and currently sole commercial product is PREMBION®, a microbiome modulator composition (MMC) targeted at the animal protein industry as a natural alternative to antibiotics in livestock farming. PREMBION is described as 100% made from brewers' spent grains, thermostable up to 100°C, non-GMO, and designed to modulate gut microbiota in animals including broiler chickens (the primary entry species), with stated expansion intent into ruminants and other species. Embion generates revenue through direct B2B sales of PREMBION to feed manufacturers and livestock producers across a regional European footprint, supplemented by a stated but undisclosed technology-licensing stream. The company's go-to-market is sales-led and consultative, explicitly courting "first movers and innovators" as partners and inviting direct contact for territory-specific inquiries.

Embion is privately held and venture-backed, having raised approximately CHF 4.5 million in a Series A round in December 2021 led by Asahi Group Holdings Ltd. with participation from undisclosed private investors, in addition to earlier pre-seed and seed financing from sources including Venture Kick and the Foundation for Innovation and Technology (FIT). Co-founders Georgios Savoglidis (CEO and Chairman), Sviatlana Siankevich (CTO) and Georgios Fengos (COO) lead the company, with Eric Nicolas serving on the board. Embion's stated sustainability targets include upcycling 1 million tons of biomass and reducing 100 million tons of CO2 emissions by 2025, addressing a globally available 40 million tons per year of brewers' spent grain waste.

Short descriptiontext

Embion Technologies is a Swiss EPFL spin-off that commercializes PREMBION®, a patented microbiome modulator derived from upcycled brewers' spent grains, sold to animal protein producers as a natural antibiotic alternative in livestock feed.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLausanne, Switzerland
HQ citystring
Lausanne
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal feed additives, biomass processing, microbiome modulators, biomass upcycling, prebiotic ingredients
Industry4 codes
PRIMARYAFADALAE
Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials)
SECONDARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)
SECONDARYAFADAKAC
Probiotics, Prebiotics & Synbiotics
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)
SECONDARYAFADAGAG
Probiotic/Direct-Fed Microbial (DFM) Premixes
Agriculture & Food Production/Animal Feed Manufacturing/Feed Premixes & Concentrates (Vitamins, Minerals, Additives)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code3 codes
  • Agricultural Prod-Livestock & Animal Specialties200
  • Biological Products, (No Disgnostic Substances)2836
  • Food And Kindred Products2000
Product category
Animal Feed Additives
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1PREMBION Product Sales
TypeOne Time License
Description

Embion generates revenue through the sale of PREMBION, their proprietary microbiome modulator product for the animal feed industry. The product is sold to livestock farmers and feed producers as a feed additive/prebiotic ingredient.

embiontech.com
2Technology Licensing
TypeLicensing Royalties
Description

The company develops biomass processing technology for functional nutrition and sustainability applications. May include licensing of their proprietary technology.

venturelab.swiss
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1PREMBION
Description

Next-generation microbiome modulator (MMC) for optimized gut health for the animal protein industry, manufactured from brewers' spent grains using a patented hydrolysis process.

embiontech.com
Core offering1 text field

Embion Technologies manufactures and sells PREMBION, a next-generation microbiome modulator composition (MMC) feed ingredient made from upcycled brewers' spent grains using a patented hydrolysis process. The product is targeted at the animal protein industry (livestock and feed producers) as a natural prebiotic alternative to antibiotics, supporting gut health, immune function, and animal performance. The company also licenses its proprietary biomass processing technology for broader functional nutrition, cosmetic, and pharma applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 40 million tons of barley (brewers' spent grains) produced and wasted globally every year
+1 more record
Product overview1 text field

Embion Technologies offers a single unified product: PREMBION®, a next-generation Microbiome Modulator Composition (MMC) designed for the animal protein industry. The product is manufactured from upcycled brewers' spent grains using Embion's patented hydrolysis technology, which breaks down cell wall structures to release specific bioactive molecules that modulate the gut microbiome in animals. PREMBION serves as a natural alternative to antibiotics in animal farming, supporting animal health, immune function, and performance from the first day of life.

Product and service1 record
1PREMBION®
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Qualified European Raw Material Suppliers
Strategic tierCoreTypeOthers
Description

Embion sources spent barley from qualified suppliers around Europe that adhere to strict standards of the feed industry.

embiontech.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major animal nutrition and health player with extensive feed additive portfolios including prebiotics, probiotics and performance enhancers; comparable as a broad incumbent serving the same animal feed customers with microbiome and gut-health solutions.

TypeDirect peer
Description

Animal health and nutrition company with nutritional specialty products and feed additives for livestock producers; comparable as a peer addressing gut health and antibiotic alternatives in animal protein.

TypeDirect peer
Description

Animal feed additive specialist offering enzymes, prebiotics and yeast products for gut health in livestock; directly comparable as a focused feed additive peer targeting the same microbiome mechanism.

TypeBroad incumbent
Description

One of the largest global animal feed and nutrition companies, offering prebiotics, probiotics and gut-health solutions across species; comparable as a broad incumbent serving Embion's target customer base.

TypeDirect peer
Description

Animal nutrition company specializing in prebiotics, probiotics, and yeast-based feed additives; directly comparable as it markets microbiome-modulating feed ingredients to livestock producers on a global basis.

6Pancosma
TypeDirect peer
Description

Specialty feed additive company offering prebiotics, probiotics and phytogenic ingredients for animal nutrition; comparable as a focused feed additive peer in the same product category as PREMBION.

TypeBroad incumbent
Description

Large specialty chemicals company with a dedicated animal nutrition feed additives business including probiotics and essential oils; comparable as a broad incumbent in the feed additive space.

8Lallemand Animal Nutrition
TypeDirect peer
Description

Specialist in microbial-based feed additives (probiotics, yeast derivatives) for livestock and poultry; directly comparable as a focused provider of microbiome solutions to the animal protein industry.

TypeBroad incumbent
Description

Global leader in microbial and fermentation-based solutions including probiotics and natural feed additives for livestock; directly comparable as a large incumbent selling microbiome-modulating products into the animal protein industry.

TypeDirect peer
Description

Ingredient manufacturer offering gut-health and immune-support feed additives for livestock and poultry; comparable as a direct competitor in functional feed ingredients targeting animal gut microbiome.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Embion Technologies

Animal Feed Additivesembiontech.com

Embion Technologies is a Swiss EPFL spin-off that commercializes PREMBION®, a patented microbiome modulator derived from upcycled brewers' spent grains, sold to animal protein producers as a natural antibiotic alternative in livestock feed.

What Embion Technologies does

Embion Technologies SA is a Swiss biotech company headquartered in Etoy, Switzerland, founded in 2016 as a spin-off from EPFL (École Polytechnique Fédérale de Lausanne). The company develops a patented hydrolysis platform that breaks down the cell wall structure of second-generation biomass — specifically brewers' spent grains — to release bioactive molecules, which it positions as a circular-economy input for functional nutrition and sustainability applications.

The company's first and currently sole commercial product is PREMBION®, a microbiome modulator composition (MMC) targeted at the animal protein industry as a natural alternative to antibiotics in livestock farming. PREMBION is described as 100% made from brewers' spent grains, thermostable up to 100°C, non-GMO, and designed to modulate gut microbiota in animals including broiler chickens (the primary entry species), with stated expansion intent into ruminants and other species. Embion generates revenue through direct B2B sales of PREMBION to feed manufacturers and livestock producers across a regional European footprint, supplemented by a stated but undisclosed technology-licensing stream. The company's go-to-market is sales-led and consultative, explicitly courting "first movers and innovators" as partners and inviting direct contact for territory-specific inquiries.

Embion is privately held and venture-backed, having raised approximately CHF 4.5 million in a Series A round in December 2021 led by Asahi Group Holdings Ltd. with participation from undisclosed private investors, in addition to earlier pre-seed and seed financing from sources including Venture Kick and the Foundation for Innovation and Technology (FIT). Co-founders Georgios Savoglidis (CEO and Chairman), Sviatlana Siankevich (CTO) and Georgios Fengos (COO) lead the company, with Eric Nicolas serving on the board. Embion's stated sustainability targets include upcycling 1 million tons of biomass and reducing 100 million tons of CO2 emissions by 2025, addressing a globally available 40 million tons per year of brewers' spent grain waste.

Embion Technologies firmographics

Firmographics
Name
Embion Technologies
Legal name
Embion Technologies SA
Website
https://embiontech.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Embion Technologies is a Swiss EPFL spin-off that commercializes PREMBION®, a patented microbiome modulator derived from upcycled brewers' spent grains, sold to animal protein producers as a natural antibiotic alternative in livestock feed.
Ownership category
akta.pro rank

Embion Technologies industry classification

Industry
Product category
Animal Feed Additives
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Agricultural Prod-Livestock & Animal Specialties (200), Biological Products, (No Disgnostic Substances) (2836), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFADALAE
Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials)
SECONDARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)
SECONDARYAFADAKAC
Probiotics, Prebiotics & Synbiotics
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)
SECONDARYAFADAGAG
Probiotic/Direct-Fed Microbial (DFM) Premixes
Agriculture & Food Production/Animal Feed Manufacturing/Feed Premixes & Concentrates (Vitamins, Minerals, Additives)

Keywords

  • Animal feed additives
  • Biomass processing
  • Microbiome modulators
  • Biomass upcycling
  • Prebiotic ingredients

Where Embion Technologies is headquartered

Location

Headquarters

HQ city
Lausanne
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Embion Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. PREMBION Product Sales: Embion generates revenue through the sale of PREMBION, their proprietary microbiome modulator product for the animal feed industry. The product is sold to livestock farmers and feed producers as a feed additive/prebiotic ingredient.
  2. Technology Licensing: The company develops biomass processing technology for functional nutrition and sustainability applications. May include licensing of their proprietary technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Embion Technologies product offering

Product offering

Core offering

Embion Technologies manufactures and sells PREMBION, a next-generation microbiome modulator composition (MMC) feed ingredient made from upcycled brewers' spent grains using a patented hydrolysis process. The product is targeted at the animal protein industry (livestock and feed producers) as a natural prebiotic alternative to antibiotics, supporting gut health, immune function, and animal performance. The company also licenses its proprietary biomass processing technology for broader functional nutrition, cosmetic, and pharma applications.

Product overview

Embion Technologies offers a single unified product: PREMBION®, a next-generation Microbiome Modulator Composition (MMC) designed for the animal protein industry. The product is manufactured from upcycled brewers' spent grains using Embion's patented hydrolysis technology, which breaks down cell wall structures to release specific bioactive molecules that modulate the gut microbiome in animals. PREMBION serves as a natural alternative to antibiotics in animal farming, supporting animal health, immune function, and performance from the first day of life.

Differentiator

Problem solved

Functional benefit

Brands

  • PREMBION: Next-generation microbiome modulator (MMC) for optimized gut health for the animal protein industry, manufactured from brewers' spent grains using a patented hydrolysis process.

Products and services

  • PREMBION®

Quantifiable outcome

  • 40 million tons of barley (brewers' spent grains) produced and wasted globally every year
  • +1 more outcomes

Companies that use Embion Technologies

Customer profile

Segments1 record

Ideal customer profiles1 record

Embion Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Embion Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Qualified European Raw Material SupplierscoreOthersEmbion sources spent barley from qualified suppliers around Europe that adhere to strict standards of the feed industry.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Embion Technologies competitors and assessment

Company assessment

Broad incumbents

  • DSM-Firmenich: Major animal nutrition and health player with extensive feed additive portfolios including prebiotics, probiotics and performance enhancers; comparable as a broad incumbent serving the same animal feed customers with microbiome and gut-health solutions.
  • Cargill Animal Nutrition: One of the largest global animal feed and nutrition companies, offering prebiotics, probiotics and gut-health solutions across species; comparable as a broad incumbent serving Embion's target customer base.
  • Evonik Animal Nutrition: Large specialty chemicals company with a dedicated animal nutrition feed additives business including probiotics and essential oils; comparable as a broad incumbent in the feed additive space.
  • Chr. Hansen (now Novonesis): Global leader in microbial and fermentation-based solutions including probiotics and natural feed additives for livestock; directly comparable as a large incumbent selling microbiome-modulating products into the animal protein industry.

Direct peers

  • Phibro Animal Health: Animal health and nutrition company with nutritional specialty products and feed additives for livestock producers; comparable as a peer addressing gut health and antibiotic alternatives in animal protein.
  • AB Vista: Animal feed additive specialist offering enzymes, prebiotics and yeast products for gut health in livestock; directly comparable as a focused feed additive peer targeting the same microbiome mechanism.
  • Alltech: Animal nutrition company specializing in prebiotics, probiotics, and yeast-based feed additives; directly comparable as it markets microbiome-modulating feed ingredients to livestock producers on a global basis.
  • Pancosma: Specialty feed additive company offering prebiotics, probiotics and phytogenic ingredients for animal nutrition; comparable as a focused feed additive peer in the same product category as PREMBION.
  • Lallemand Animal Nutrition: Specialist in microbial-based feed additives (probiotics, yeast derivatives) for livestock and poultry; directly comparable as a focused provider of microbiome solutions to the animal protein industry.
  • Kemin Industries: Ingredient manufacturer offering gut-health and immune-support feed additives for livestock and poultry; comparable as a direct competitor in functional feed ingredients targeting animal gut microbiome.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Embion Technologies social profiles

Digital presence

Embion Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Embion Technologies leadership team

Management profile

Number of profiles

Profiles4 records

Embion Technologies funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Embion Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Embion Technologies

What does Embion Technologies do?

Embion Technologies manufactures and sells PREMBION, a next-generation microbiome modulator composition (MMC) feed ingredient made from upcycled brewers' spent grains using a patented hydrolysis process. The product is targeted at the animal protein industry (livestock and feed producers) as a natural prebiotic alternative to antibiotics, supporting gut health, immune function, and animal performance. The company also licenses its proprietary biomass processing technology for broader functional nutrition, cosmetic, and pharma applications.

Is Embion Technologies a public or private company?

Embion Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was Embion Technologies founded?

Embion Technologies was founded in 2016. It employs 1 to 10 people.

Where is Embion Technologies based?

Embion Technologies is headquartered in Lausanne, Switzerland, in the Europe region.

How does Embion Technologies make money?

Two revenue lines are on record. PREMBION Product Sales are the primary driver. The others are technology Licensing.

Who are Embion Technologies's main competitors?

Broad incumbents on record are DSM-Firmenich, Cargill Animal Nutrition, Evonik Animal Nutrition and Chr. Hansen (now Novonesis). Direct peers are Phibro Animal Health, AB Vista, Alltech, Pancosma, Lallemand Animal Nutrition and Kemin Industries.

Does Embion Technologies have an API?

No public API is recorded for Embion Technologies.

What industry is Embion Technologies in?

Embion Technologies's product category is Animal Feed Additives. Its primary akta.pro industry code is AFADALAE, Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials), with a secondary code of HLAAAFAJ, Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery). Its NAICS code is 325414 and its SIC code is 200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chEmbion and Proton awarded as Technology Pioneer by World Economic ForumThe World Economic Forum selected Embion and Proton as Technology Pioneers of 2022, among 100 companies from 30 economies. Embion produces biomass-based ingredients for animal nutrition and food, while Proton builds a privacy-focused internet ecosystem with over 50 million users.VenturelabEmbion raises CHF 4.5 million to accelerate the commercialization in breakthrough biomass processing for functional nutrition innovationEmbion Technologies has closed a CHF 4.5 million Series A financing round led by ASAHI Group Holdings Ltd to accelerate the commercialization of its biomass processing technology. The company plans to scale production capabilities and double its team size within 18 months to expand its business in functional nutrition and secure intellectual property. This investment supports Embion's goal to upcycle industrial biomass, aiming to save significant CO2 emissions while providing high-value ingredients for the health and nutrition industries.startupticker.chEmbion closes ASAHI led CHF 4.5M Series A RoundASAHI Group Holdings Ltd. led a CHF 4.5 million Series A financing round for Embion Technologies SA, an EPFL spin-off specializing in biomass processing technology. The company plans to use the funds to scale production capabilities and double its team size within 18 months to expand into animal and human health markets.startupticker.chEmbion receives Innosuisse grantEmbion, an EPFL spin-off, received a CHF 0.5 million Innosuisse grant to advance biomass-to-biopolymers technology. The project develops renewable biopolymer materials (PEF) that could substitute PET, with applications in packaging and textiles. The grant supplements a CHF 325k convertible note from a seed round.